CIK 0001375195
CRTG CORETEC GROUP INC.
Insider trading from SEC Form 4. Last filing Nov 26, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Signals
Open-market buys and sells at CORETEC GROUP INC., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 7 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | Birge Watkins director | JOther Non-Qualified Stock Option (Right to Buy)derivative | +3,300,000 | $0.00 | $0 | 3,300,000 | Nov 26, 2024 |
| Nov 18, 2024 | Victor F Keen director | JOther Non-Qualified Stock Option (Right to Buy)derivative | +3,300,000 | $0.00 | $0 | 3,300,000 | Nov 21, 2024 |
| Nov 18, 2024 | Seonkee Kim director, other | JOther Non-Qualified Stock Option (Right to Buy)derivative | +3,300,000 | $0.00 | $0 | 3,300,000 | Nov 21, 2024 |
| Nov 18, 2024 | David Lee director | JOther Non-Qualified Stock Option (Right to Buy)derivative | +3,300,000 | $0.00 | $0 | 3,300,000 | Nov 21, 2024 |
| Nov 18, 2024 | Robert McCollar director | JOther Non-Qualified Stock Option (Right to Buy)derivative | +3,300,000 | $0.00 | $0 | 3,300,000 | Nov 21, 2024 |
| Nov 18, 2024 | Jung Min Lee Chief Operating Officer | JOther Non-Qualified Stock Option (Right to Buy)derivative | +3,300,000 | $0.00 | $0 | 3,300,000 | Nov 21, 2024 |
| Nov 18, 2024 | Elbert Michael Ussery Co-Chairman and CEO | JOther Non-Qualified Stock Option (Right to Buy)derivative | +3,300,000 | $0.00 | $0 | 3,300,000 | Nov 21, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Victor F Keendirector
- Seonkee Kimdirector, other
- David Leedirector
- Jung Min LeeChief Operating Officer
- Robert McCollardirector
- Elbert Michael UsseryCo-Chairman and CEO
- Birge Watkinsdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.